Background: Electroconvulsive therapy (ECT) is known to increase intraocular pressure (IOP). Data on the safety of ECT in patients after eye surgery remain scarce, and data on the influence of modern anesthetic drugs on IOP during an ECT procedure are lacking.
Methods: We describe the case of a 49-year old woman, treated with ECT for depression, 13 days after phacoemulsification and intraocular lens implantation.
Results: Baseline IOP (15 mm Hg OD/14 mm Hg OS) dropped after administration of propofol (8 mm Hg OD/10 mm Hg OS) and then increased after succinylcholine (19 mm Hg OD/OS) to further increase during the seizure (34 mm Hg OD/OS not available). Our patient had 9 treatments, until remission, without any complication.
Conclusions: Recent cataract surgery should not be seen as a contraindication to ECT. Advances in the technique of cataract surgery have improved wound healing, and the transient IOP increase is, probably, of limited importance. Further study on the influence of contemporary anesthesia regimens on IOP is warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/YCT.0b013e318279c1ba | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Functional connectivity analyses of individual hippocampal subregions in major depressive disorder with electroconvulsive therapy.
Psychoradiology
December 2024
Department of Neurology, the First Hospital of Anhui Medical University, Hefei 230022, China.
Background: The hippocampus has been widely reported to be involved in the neuropathology of major depressive disorder (MDD). All the previous researches adopted group-level hippocampus subregions atlas to investigate abnormal functional connectivities in MDD in absence of capturing individual variability. In addition, the molecular basis of functional impairments of hippocampal subregions in MDD remains elusive.
View Article and Find Full Text PDFTrajectory of peripheral inflammation during index ECT in association with clinical outcomes in treatment-resistant depression.
Brain Behav Immun Health
February 2025
Department of Psychiatry & Biobehavioral Sciences, Jane and Terry Semel Institute for Neuroscience and Human Behavior, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
Background: Electroconvulsive therapy (ECT) is a highly efficacious intervention for severe and intractable depression. Evidence suggests ECT provokes an initial acute inflammatory response that subsequently decreases with repeated administration. However, relationships between inflammatory changes and clinical effects are unclear.
View Article and Find Full Text PDFImpact of electroconvulsive therapy on inflammatory markers in patients with severe mental disorders.
J Psychiatr Res
January 2025
Department of Psychiatry, Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkiye.
Objective: Evaluation of the effects of electroconvulsive therapy (ECT) on systemic inflammatory markers in patients with severe mental disorders and determination of potential clinical predictors of treatment response.
Methods: The current retrospective cohort study included 156 patients with psychotic and mood disorders who underwent ECT. Pre- and post-ECT blood samples were collected to assess inflammatory markers, including C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), and other complete blood count derived indices.
Background: Electroconvulsive therapy (ECT) is a well-established and effective treatment for severe depression and other conditions. Though ECT induces a generalized seizure, it is unclear why seizures are therapeutic. This study analyzed relationships between pre-treatment brain morphology, stimulation dose, and seizure duration to better understand ECT-induced seizures.
View Article and Find Full Text PDFEfficacy of Modified Electroconvulsive Therapy in Treatment-Resistant Schizophrenia.
Alpha Psychiatry
November 2024
Department of Psychiatry, Wuhan Wudong Hospital, Wuhan, China.
Objective: The aim of the study was to investigate the therapeutic effects of modified electroconvulsive therapy (MECT) in combination with risperidone tablets and psychotherapy in the treatment of patients with treatment-resistant schizophrenia (TRS).
Methods: Patients with TRS admitted to the psychiatric department of our hospital between January 2018 and December 2019 were selected as study participants. They were randomly divided into a control group and a study group, with the control group receiving risperidone tablets and psychotherapy, and the study group undergoing MECT as well as the control group treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!